Editorial of special column on Drug targets and drug development for Alzheimer's disease

Acta Pharm Sin B. 2022 Apr;12(4):1686-1687. doi: 10.1016/j.apsb.2022.03.007. Epub 2022 Apr 22.

Authors

Wen-Xing Ding¹, Russell H Swerdlow²

Affiliations

¹ Department of Pharmacology, Toxicology and Therapeutics, Department of Internal Medicine, the University of Kansas Medical Center, Kansas City, KS 66160, USA.
² Department of Neurology, the University of Kansas Medical Center, Kansas City, KS 66160, USA.

No abstract available

Publication types

Editorial

Grants and funding

R01 AG072895/AG/NIA NIH HHS/United States